Actuals vs. estimates

Verdict

• Adjusted diluted EPS of $2.36 beat the $2.30 estimate by 2.6% and set a record quarterly level, on net revenues of $11.4 billion, up 7.1% organically and 5.5% in dollars.
• Adjusted operating income passed $5 billion for the first time and grew 10.5% organically, with adjusted operating margin close to 45%, up 130 basis points organically.
• Every full-year range was left intact - organic net revenues +5% to +7%, organic operating income +7% to +9%, currency-neutral adjusted diluted EPS +7.5% to +9.5%, adjusted diluted EPS $8.29-$8.44 - but delivery was steered to the midpoint or lower half of the profit and EPS brackets.
• The United States is the swing quarter: segment SG&A of around $370 million in Q3 rises a further 10% in Q4, and Q4 U.S. adjusted operating company income is guided to around zero or slightly negative as the flagship ZYN range moves from 15 to 20 pouches at the 15-count price, about 25% less revenue per pouch.
• The one thing that matters: the guide-down sits inside a beat and it is cost and timing, not demand - roughly one point of EPS growth lost to energy-led input inflation and to the bombing of Ukrainian supply facilities, alongside a Q4 U.S. profit deliberately spent away.

Guidance & KPIs

Management commentary

• The steer to the midpoint or lower half was quantified as half a point of EPS growth from geopolitically driven input-cost inflation and half a point from three bombings of Ukrainian supply-chain facilities; without them the CFO put delivery in the mid to upper half of the range.
• The Q3 U.S. spend level of around $370 million is the run rate to carry into next year, including the drag from the low loading of the new Colorado facility, with proper 2027 guidance deferred to February.
• ZYN's U.S. category offtake share rose an estimated 1.4 points from June to September, which management reads as the expanded dry flavour range and the 9 mg and 11 mg Ultra variants pulling back consumers who had left for competitors.
• On Germany's excise step-up to between EUR 0.83 and EUR 0.88 from January 1, the CFO argued the category advantage survives: "the differential with HTU has been retained, and therefore, HTU retains a tax advantage versus the underlying cigarette tax".
• Japan's 2027 excise change is a JPY 12 increase applied to both heated tobacco and cigarettes, framed as more progressive than 2026's asymmetric JPY 40 and JPY 20 increases on heated tobacco alone.

Quality of earnings

• The EPS beat is operational, achieved against a tax and currency drag. Adjusted diluted EPS rose 5.4% in dollars and about 6% excluding currency, absorbing a $0.01 unfavourable currency impact and an unfavourable comparison with a low prior-year tax rate that cost roughly 4 percentage points of Q3 EPS growth.
• Combustibles, not smoke-free, carried the quarter. Combustible pricing of 8.9% and a one-off benefit from restructured distribution terms drove the revenue upside, while smoke-free shipments grew only 2.7% and international smoke-free price and mix slowed; the distribution benefit is not expected to be significant in Q4.
• The U.S. top line flatters the underlying run rate. U.S. net revenues rose almost 23% and gross profit 24% against prior-year promotional comparisons, yet adjusted operating company income grew just 1.5% as commercial investment stepped up.

Gotchas & watch items

• ZYN's U.S. shipment growth of 4.2% to 3.2 billion pouches runs ahead of third-party scanner data pointing to a mid-single-digit volume decline; management attributes the gap to lapping September 2025 promotions, which lifts the figure to 13%, and to pipelining of the new dry flavours and Ultra variants.
• The move to 20-count cans cuts revenue per pouch by about 25% and carries a lagging revenue effect for three quarters on the 1.5 mg, 3 mg and 6 mg flagship variants, against a Q4 U.S. adjusted operating company income guided to around zero.
• Japan's Q3 heated-tobacco adjusted IMS growth of 3.4% includes pantry loading ahead of the October JPY 20 price increase; underlying growth was 1.3%, and Q4 is expected to be softer as that reverses.
• HTU shipments are now guided to run slightly below adjusted in-market sales for the full year, with Q4 shipments of 39.5-40.5 billion units drawing trade inventory down rather than adding to it.

Last quarter's watch items: what happened

• No watch items on file from a prior quarter - this is the first tracked quarter for this company.

Next quarter: the 2-3 things that matter

• ZYN U.S. shipment volumes and category share through the 15-to-20 pouch transition Baseline: 3.2 billion pouches in Q3 2026, up 4.2%, with offtake share up an estimated 1.4 points June to September Confirms: Q4 2026 shipments broadly in line to modestly above 3.2 billion pouches with the share gain held or extended Breaks: Q4 2026 shipments below Q3 levels, or offtake share giving back the June-to-September gain Check in: Q4 2026. Source: Call remarks on U.S. ZYN volumes and Q4 shipment guidance
• U.S. segment profitability once the Q4 investment quarter passes Baseline: Q3 2026 U.S. adjusted operating company income up 1.5% on SG&A of around $370 million; Q4 guided to around zero or slightly negative with SG&A up a further 10% Confirms: U.S. adjusted operating company income back in growth in Q1 2027 with SG&A near the Q3 2026 run rate Breaks: U.S. adjusted operating company income flat or negative in Q1 2027, or SG&A above the Q3 2026 run rate Check in: Q1 2027. Source: Call remarks on Q4 U.S. operating company income and the Q3 spend run rate
• Whether input-cost inflation stays at the guided half point of EPS growth Baseline: Half a percentage point of 2026 adjusted diluted EPS growth from input-cost inflation plus a similar amount from Ukraine disruption, about one point combined Confirms: Full-year 2026 adjusted diluted EPS inside $8.29-$8.44 with no larger cost drag named for 2027 Breaks: Full-year adjusted diluted EPS below $8.29, or a bigger inflation drag carried into the 2027 outlook Check in: Q4 2026. Source: Call remarks on energy-led input inflation and Ukraine supply-chain disruption